mTOR aggravated CD4+ T cell pyroptosis by regulating the PPARγ-Nrf2 pathway in sepsis

Guoyu Zhao1, Yawen Xie1, Xianli Lei1

  • 1Department of Critical Care Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100730, China.

PubMed

Insights

Sepsis triggers CD4+ T cell death via pyroptosis, a programmed cell death. The mTOR-PPARγ-Nrf2 pathway regulates this process, offering potential therapeutic targets for sepsis-induced immunosuppression.

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Medicine

Background:

  • Sepsis involves a systemic inflammatory response due to infection.
  • CD4+ T cell reduction is a key factor in sepsis-induced immunosuppression.
  • Pyroptosis, a form of programmed necrosis, contributes to lymphocytopenia in sepsis.

Purpose of the Study:

  • To investigate the role of the mTOR-PPARγ pathway in sepsis-induced CD4+ T cell depletion.
  • To elucidate the underlying molecular mechanisms connecting mTOR, PPARγ, and T cell pyroptosis in sepsis.

Main Methods:

  • Cecal ligation and puncture (CLP) sepsis mouse model.
  • Observation of mTOR activation, pyroptosis, and PPARγ-Nrf2 suppression.
  • Utilized genetically modified mice with T cell-specific knockout of mTOR or TSC1.

Main Results:

  • mTOR activation was observed in septic mice.
  • mTOR negatively regulated the PPARγ-Nrf2 signaling pathway.
  • mTOR mediated CD4+ T cell pyroptosis in septic mice.

Conclusions:

  • The mTOR-PPARγ-Nrf2 signaling pathway is critical in mediating CD4+ T cell pyroptosis during sepsis.
  • Dysregulation of this pathway contributes to CD4+ T cell depletion and immunosuppression in sepsis.
  • Targeting the mTOR-PPARγ-Nrf2 pathway may offer therapeutic strategies for sepsis.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.3K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K